If you’re considering detox for yourself or someone you care about, the most useful thing anyone can give you is an accurate picture of what actually happens: not a reassuring summary, but a real walkthrough.
This guide moves through the detox process chronologically: intake, the acute withdrawal phase, stabilization and discharge planning. Where relevant, it covers the clinical tools and medications used, what the medical team is watching for and what the research says about outcomes. If you want help identifying the right detox program for your specific situation, call the National Rehab Hotline. The service is free, confidential and available around the clock.
What Detox Is — and What It Isn’t
A detox center, or medical detoxification facility, is a clinically supervised environment where the body clears itself of substances while medical staff manage the physiological risks of withdrawal. It’s not the same as rehabilitation. Detox addresses physical dependence; rehabilitation addresses the behavioral, psychological and social dimensions of addiction. Both are necessary for durable recovery, and confusing one with the other is one of the most common reasons people relapse shortly after discharge.
Most inpatient detox programs run between 3 and 10 days. Length of stay depends on the substance involved, the severity of physical dependence, the patient’s medical history and how they respond to treatment. Some residential facilities incorporate detox as a first phase, keeping patients on-site through the transition into structured programming.
The medical rationale for supervised detox is clearest with alcohol and benzodiazepines, where withdrawal carries genuine life-threatening risk. Alcohol withdrawal can produce seizures and a syndrome called delirium tremens (DTs) — characterized by severe confusion, cardiovascular instability and hallucinations — with a mortality rate that rises sharply without medical intervention. Opioid withdrawal, while rarely fatal in otherwise healthy individuals, causes intense physical distress that drives the overwhelming majority of unsupported patients back to use within hours. Stimulant withdrawal is less medically dangerous but can produce severe psychiatric symptoms that benefit from clinical monitoring.
Intake and Assessment
Most facilities conduct a preliminary phone screening before admission. The purpose is not gatekeeping; it’s preparation. Clinical staff need to know what they’re receiving before the patient arrives. Expect questions about substances used, frequency and quantity of use, date of last use, prior withdrawal history, current medications and any co-occurring medical or psychiatric conditions. Insurance and financial questions are typically handled during this call as well.
On arrival, a more comprehensive bio-psychosocial assessment is conducted in person. This covers physical health, mental health history, substance use history and social circumstances. Vital signs are taken, bloodwork is ordered and in most facilities, a physician or nurse practitioner meets with the patient within the first few hours to establish an individualized care plan.
The American Society of Addiction Medicine (ASAM) criteria are widely used to determine appropriate level of care. These criteria evaluate six dimensions — intoxication and withdrawal potential, medical conditions, emotional and behavioral conditions, readiness to change, relapse potential and recovery environment — and guide placement decisions across the continuum of care.
What to bring: Government-issued identification, insurance card, any current prescription medications in original bottles and a small bag of personal items. Most inpatient detox units restrict phone use during the first 24 to 48 hours. Policies vary by facility.
Day One: Stabilization
The first 24 hours center on medical stabilization. Vital signs are monitored frequently: blood pressure, heart rate, respiratory rate, temperature and oxygen saturation. The clinical picture in this window is shaped heavily by the time elapsed since last use.
For alcohol-dependent patients, the Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar) scale is the standard tool for measuring withdrawal severity. It evaluates 10 symptom domains — nausea, tremor, sweating, anxiety, agitation, perceptual disturbances, headache and others — on a scored scale that guides medication dosing. Benzodiazepines, most commonly diazepam (Valium) or lorazepam (Ativan), are administered on a symptom-triggered or fixed-tapering schedule to reduce seizure risk.
For patients in opioid withdrawal, the Clinical Opiate Withdrawal Scale (COWS) serves a parallel function. Buprenorphine-containing medications (Suboxone) or methadone may be initiated in this window, depending on the facility’s protocols and the patient’s COWS score. Clonidine, an alpha-2 agonist, is frequently used adjunctively to manage cardiovascular symptoms — elevated heart rate and blood pressure — that accompany opioid withdrawal.
For stimulant withdrawal, no FDA-approved medications target the withdrawal process directly. Supportive care — hydration, nutritional support, sleep aids and symptom management — is the standard approach.
Rest is both expected and medically appropriate on day one. The physical and emotional demands of this transition are significant, and sleep, when possible, is part of the treatment.
Days Two Through Four: Peak Withdrawal
Withdrawal symptoms typically reach their peak intensity during this window, though the timeline varies by substance.
Alcohol withdrawal peaks between 24 and 72 hours after the last drink. Symptoms can include sweating, tremor, nausea, high blood pressure, rapid heartbeat and in severe cases, auditory or visual hallucinations and tonic-clonic seizures. Delirium tremens, when it occurs, typically emerges 48 to 96 hours after last use. Medical monitoring during this phase is intensive.
Opioid withdrawal from short-acting opioids — heroin, oxycodone, hydrocodone — peaks around 36 to 72 hours post-cessation. Long-acting opioids, including methadone and extended-release formulations, produce a more protracted withdrawal that may not peak for several days. Symptom burden includes severe muscle pain, chills, sweating, nausea, vomiting, diarrhea, insomnia and marked anxiety. Craving is intense during this phase and a primary driver of treatment dropout.
Benzodiazepine withdrawal is clinically complex and shares many features with alcohol withdrawal, including seizure risk. Tapering schedules are individualized and may extend well beyond the acute inpatient phase. The risk of protracted withdrawal — a syndrome of persistent low-grade symptoms lasting weeks to months — is higher with benzodiazepines than with most other substances and warrants explicit attention during discharge planning.
Structured programming is typically minimal during peak withdrawal. Patients are resting, managing symptoms and under close clinical observation. Brief check-ins with a counselor are common, but treatment-focused group work is generally postponed.
Days Four Through Six: Stabilization and Early Programming
As acute symptoms resolve, the daily structure shifts. Patients become more alert, more communicative and more capable of engaging with educational and therapeutic content. This is the phase where detox begins to resemble early rehabilitation.
Group sessions introduced during this period typically cover foundational content: the neurobiology of addiction, the distinction between physical dependence and addiction, what to expect in early recovery and an introduction to continuing care options. Some facilities incorporate evidence-based frameworks such as motivational interviewing (MI) or cognitive behavioral therapy (CBT) into this early programming.
Nutrition and sleep begin to normalize. Exercise, mindfulness and other supportive modalities may be offered depending on the facility’s approach.
One important clinical note: The subjective experience of feeling better doesn’t mean the withdrawal process is complete. Post-acute withdrawal syndrome (PAWS) — a constellation of persistent symptoms including mood instability, sleep disruption, cognitive fog and intermittent craving — is common across multiple substance classes and can persist for weeks to months after acute detox. Patients who aren’t informed about PAWS are at higher risk of interpreting these symptoms as evidence that they can’t recover.
Discharge Planning: The Most Important Phase
Research consistently shows that detox without a structured transition to continuing care produces poor outcomes. A 2014 analysis published in the Journal of Substance Abuse Treatment found that patients who received direct transfer from detox to residential or intensive outpatient treatment had significantly lower rates of relapse at 30 and 90 days compared to those who were discharged without a follow-up plan in place. Discharge planning isn’t an administrative afterthought — it’s a clinical priority.
Continuing care options exist across a range of intensity:
- Residential treatment provides 24-hour support in a structured, substance-free environment. Programs typically run 30, 60 or 90 days and include individual therapy, group programming and case management. Residential treatment is appropriate for patients with severe use disorder, unstable home environments or co-occurring psychiatric conditions.
- Partial hospitalization programs (PHP) offer hospital-based clinical programming for several hours per day, typically 5 days per week, while patients return home or to a sober living environment in the evenings.
- Intensive outpatient programs (IOP) provide structured group and individual therapy several times per week. IOP is appropriate for patients with stable housing, strong social support and a lower severity profile.
- Medication-assisted treatment (MAT) — ongoing management with FDA-approved medications such as buprenorphine, naltrexone (Vivitrol) or methadone — substantially reduces relapse rates for opioid and alcohol use disorder and should be discussed as a continuing care option for appropriate patients regardless of which level of care they transition into.
- Support groups, including Alcoholics Anonymous, Narcotics Anonymous and SMART Recovery, provide ongoing peer support and are associated with improved long-term outcomes when combined with professional treatment.
If the discharge planning process at your facility feels insufficient or you need help identifying the right level of continuing care, the National Rehab Hotline can help. We work with individuals and families to navigate insurance coverage, identify quality programs and match treatment to individual circumstances at no cost.
Frequently Asked Questions
- Will I Be in a Room by Myself?
Accommodations vary by facility type. Medical detox units often provide individual rooms given the monitoring requirements; residential-style programs may offer shared rooms. This is a reasonable question to ask during the intake phone call. - Can Family Visit?
Most programs restrict visitation during the first 48 to 72 hours. This is intentional — the acute withdrawal phase requires rest and clinical focus. Visitation and phone access typically increase as patients stabilize. - Is Detox Covered by Insurance?
In most cases, yes. The Mental Health Parity and Addiction Equity Act (MHPAEA) requires most insurance plans to cover substance use treatment at parity with medical and surgical care. Medicaid covers medical detox in most states. Coverage details vary by plan; our team at the National Rehab Hotline can help you verify your benefits before you commit to a facility. - What If I’ve Been Through Detox Before?
Prior treatment attempts don’t reduce the likelihood of success in subsequent attempts. Relapse is a recognized feature of chronic addiction, and research doesn’t support the idea that patients who’ve relapsed are poor candidates for treatment. What prior attempts often indicate is that the level or type of continuing care following detox needs to be adjusted. - What About Work and Family Obligations?
The Family and Medical Leave Act (FMLA) provides eligible employees up to 12 weeks of unpaid, job-protected leave for substance use treatment. Many employers also offer Employee Assistance Programs (EAPs) that cover or partially cover treatment costs and provide logistical support. Planning these logistics before admission reduces a significant source of resistance to entering care.
Getting the Right Help
Detox is a medical event. Its outcomes depend significantly on clinical quality, appropriate medication protocols and the presence of a structured transition plan. Not all facilities meet the same standard of care, and the difference matters.
The National Rehab Hotline exists to help people make informed decisions about treatment, not to funnel them toward a particular program. We refer based on clinical fit, insurance coverage and individual circumstances. If you’re trying to determine whether detox is the right first step, which facility to choose or what comes after, call us. The conversation is free and confidential.
NationalRehabHotline.org provides free substance use treatment referrals and guidance 24 hours a day, 7 days a week. We aren’t a treatment facility. If you’re experiencing a medical emergency or severe withdrawal symptoms, call 911 immediately.
